Breast Reconstruction Market SWOT Analysis 2027 | Leading Players Mentor Worldwide, Sientra, Hansbiomed, Groupe Sebbin SAS, Establishment Labs

According to a new market research study titled 'Breast Reconstruction Market to 2025 - Global Analysis and Forecasts by Technology, Type and Placement, the global breast reconstruction market was valued at US$ 526.5 Mn in 2017 and is estimated to reach US$ 684.5 Mn by 2025. The report highlights the trends prevalent in the global breast reconstruction market and the factors driving the market along with those that act as deterrents to its growth.

The global breast reconstruction market is a matured market in the developing countries as well as developing nations worldwide. The breast reconstruction can either be done by using tissues from the belly, buttocks, back or other parts of the body which is termed as autologous breast reconstruction or with the help of saline or silicone gel implants. According to the breastcancercare.org.uk, one new case of breast cancer in the U.K. is diagnosed every 10 minutes. Thus, increasing prevalence of breast cancer is expected to increase the demand for breast reconstruction procedures thereby propelling the market growth.

Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100001298/?opr-10144

The key players operating in the breast reconstruction market worldwide include Allergan Plc, Mentor Worldwide LLC, Sientra Inc., GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, Hansbiomed Co. Ltd., Ideal Implant Incorporated, Guangzhou Wanhe Plastic Materials Co., Ltd., Establishment Labs S.A., Groupe Sebbin SAS among others.

The market for breast reconstruction is well established in the North American region, owing to the awareness regarding medical practices and technological developments in the process of breast reconstruction. Various market players have improved their products for the breast reconstruction procedures. Therefore, they are developing more number of advanced and new products for the reconstruction procedures. For instance, Allergan Plc received the FDA approval for marketing the NATRELLE INSPIRA SoftTouch breast reconstruction, which offers women undergoing breast reconstruction, augmentation or revision surgery a new medium firmness gel, implant option. Asia Pacific is expected to grow with the highest CAGR of 3.9% during the forecast period.

In addition, increasing prevalence of breast cancer across the globe is expected to be another key driver for the growth of breast reconstruction procedures. According to breastcancer.org, as of January 2018, over 3.1 million women in the U.S. were reported with a history of breast cancer, which includes the patients currently undergoing a treatment, as well as finished their treatment. Moreover, according to the National Cancer Registry, China, the incidence of breast cancer has increased by 3.5% from 2000 to 2013 in China. Similarly, according to the breastcancercare.org.uk, as many as 691,000 women diagnosed with breast cancer were alive in the UK. This number is estimated to reach 840,000 by 2020. Similar trends of rise in number of breast cancer cases were found in other parts of the world and such trend backed by increasing preference for reconstruction procedures is expected to bolster the market during the forecast period.

Inquiry for Discount @ https://www.theinsightpartners.com/discount/TIPHE100001298/?opr-10144

Strategic Insights

Partnership/acquisition, and product launch & approvals were observed as the most adopted strategy in global breast reconstruction industry. Few of the acquisition, partnership, product launches and approvals made by the players in the market are listed below:

2018: Sientra Inc. received approval from U.S. Food and Drug Administration (FDA) for the PMA supplement permitting the commercialization of OPUS-branded breast implant products which are manufactured by Vesta, a Lubrizol LifeSciences company.

2017: Allergan acquired Keller Medical, Inc. a medical device company which develops Keller Funnel.

2016: GC Aesthetics launched new products in Brazil Market. The company introduced Matrix and IMPLEO in Brazil market. Nagor (UK) subsidiary of GC Aesthetics IMPLEO is produced and Eurosilicone (France) where The Matrix is developed.

2015: Mentor introduced MENTOR ARTOURA breast tissue expander which is the first and only tissue expander capable of providing precisely controlled pocket formation for predictable expansion outcomes.

TABLE OF CONTENTS

1. INTRODUCTION 25
1.1 SCOPE OF THE STUDY 25
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 25

2. GLOBAL BREAST RECONSTRUCTION MARKET - KEY TAKEAWAYS 26

3. GLOBAL BREAST RECONSTRUCTION MARKET - MARKET LANDSCAPE 29
3.1 OVERVIEW 29
3.2 MARKET SEGMENTATION 29
3.2.1 Global Breast Reconstruction Market - By Technology 30
3.2.2 Global Breast Reconstruction Market - By Type 30
3.2.3 Global Breast Reconstruction Market - By Placement 31
3.2.4 Global Breast Reconstruction Market - By Geography 31
3.3 PEST ANALYSIS 32
3.3.1 North America - PEST Analysis 32
3.3.2 Europe - PEST Analysis 34
3.3.3 Asia Pacific - PEST Analysis 36
3.3.4 Middle East and Africa (MEA) - PEST Analysis 38
3.3.5 South and Central America - PEST Analysis 40

4. GLOBAL BREAST RECONSTRUCTION MARKET - KEY MARKET DYNAMICS 42
4.1 KEY MARKET DRIVERS 42
4.1.1 Increasing Prevalence of Breast Cancer 42
4.1.2 New Product Launches & FDA Approvals 42
4.1.3 Growing Number of Cosmetic and Breast Augmentation Procedures 43
4.2 KEY MARKET RESTRAINTS 43
4.2.1 Post-Surgical Complications 43
4.2.2 Low Awareness Among Populace Coupled With High Cost Of Surgical Procedures 43
4.3 KEY MARKET OPPORTUNITIES 44
4.3.1 Development of Innovative Breast Reconstruction Products 44
4.4 FUTURE TRENDS 44
4.4.1 Shift Towards Autologous/Flap Reconstruction 44
4.5 IMPACT ANALYSIS 45

Purchase this Report @ https://www.theinsightpartners.com/buy/TIPHE100001298/?opr-10144

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.